Review
World J Pharmacol
3(4):39-55.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.39
Abstract (1854)
|
Core Tip (1625)
|
Full Article (HTML) (15057)
|
Figures (1-3) (363)
|
Tables (1-5) (400)
|
Full Article (PDF)-1451K (1232)
|
Peer-Review Report-94K (375)
|
Answering Reviewers-72K (295)
|
Received: 06/26/2014
|
Revised: 09/09/2014
|
Accepted: 10/10/2014
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (60)
|
Total Visits (27694)
|
Similar Articles (6)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):56-71.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.56
Abstract (1879)
|
Core Tip (1525)
|
Full Article (HTML) (8779)
|
Figures (1-1) (679)
|
Tables (1-3) (333)
|
Full Article (PDF)-1210K (727)
|
Peer-Review Report-98K (315)
|
Answering Reviewers-99K (263)
|
Received: 07/01/2014
|
Revised: 08/01/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (18011)
|
Similar Articles (161)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):72-85.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.72
Abstract (1702)
|
Core Tip (1560)
|
Full Article (HTML) (9463)
|
Figures (1-4) (1119)
|
Tables (1-1) (336)
|
Full Article (PDF)-1374K (1055)
|
Peer-Review Report-105K (306)
|
Answering Reviewers-58K (387)
|
Received: 07/28/2014
|
Revised: 08/29/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (19571)
|
Similar Articles (7)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):86-96.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.86
Abstract (1555)
|
Core Tip (1524)
|
Full Article (HTML) (7060)
|
Figures (1-3) (456)
|
Full Article (PDF)-2317K (793)
|
Peer-Review Report-102K (304)
|
Answering Reviewers-250K (365)
|
Received: 07/28/2014
|
Revised: 10/01/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (15205)
|
Similar Articles (2)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):97-109.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.97
Abstract (1342)
|
Core Tip (1238)
|
Full Article (HTML) (5667)
|
Figures (1-1) (331)
|
Tables (1-4) (338)
|
Full Article (PDF)-1455K (686)
|
Peer-Review Report-129K (184)
|
Answering Reviewers-81K (207)
|
Received: 06/28/2014
|
Revised: 10/02/2014
|
Accepted: 11/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (12855)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Harnessing pharmacological knowledge for personalized medicine and pharmacotyping: Challenges and lessons learned

World J Pharmacol
3(4):110-119.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.110
Abstract (1390)
|
Core Tip (1160)
|
Full Article (HTML) (3889)
|
Figures (1-1) (359)
|
Tables (1-1) (319)
|
Full Article (PDF)-2534K (519)
|
Peer-Review Report-98K (248)
|
Answering Reviewers-19K (178)
|
Received: 06/12/2014
|
Revised: 07/03/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (11750)
|
Similar Articles (7)
|
Timeline of Article Publication (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):120-139.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.120
Abstract (1723)
|
Core Tip (1355)
|
Full Article (HTML) (8310)
|
Figures (1-2) (432)
|
Tables (1-1) (276)
|
Full Article (PDF)-1376K (728)
|
Peer-Review Report-116K (401)
|
Answering Reviewers-78K (331)
|
Received: 06/29/2014
|
Revised: 09/01/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (19527)
|
Similar Articles (67)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):140-152.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.140
Abstract (1695)
|
Core Tip (1547)
|
Full Article (HTML) (7735)
|
Figures (1-2) (312)
|
Tables (1-1) (294)
|
Full Article (PDF)-2415K (509)
|
Peer-Review Report-106K (379)
|
Answering Reviewers-72K (280)
|
Received: 06/27/2014
|
Revised: 10/02/2014
|
Accepted: 11/03/2014
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (15759)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(1)
|
Open
Minireviews
Pharmacological role of efflux transporters: Clinical implications for medication use during breastfeeding

World J Pharmacol
3(4):153-161.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.153
Abstract (1541)
|
Core Tip (1417)
|
Full Article (HTML) (5447)
|
Figures (1-1) (321)
|
Full Article (PDF)-1040K (567)
|
Peer-Review Report-104K (330)
|
Answering Reviewers-60K (243)
|
Received: 06/28/2014
|
Revised: 09/03/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (13200)
|
Similar Articles (10)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):162-173.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.162
Abstract (1582)
|
Core Tip (1624)
|
Full Article (HTML) (6963)
|
Figures (1-2) (362)
|
Tables (1-1) (297)
|
Full Article (PDF)-4747K (785)
|
Peer-Review Report-116K (338)
|
Answering Reviewers-128K (326)
|
Received: 06/27/2014
|
Revised: 08/07/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (18328)
|
Similar Articles (2)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):174-185.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.174
Abstract (1288)
|
Core Tip (1072)
|
Full Article (HTML) (4411)
|
Tables (1-1) (341)
|
Full Article (PDF)-1054K (405)
|
Peer-Review Report-106K (282)
|
Answering Reviewers-75K (198)
|
Received: 07/29/2014
|
Revised: 10/02/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (10973)
|
Similar Articles (18)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):186-192.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.186
Abstract (1503)
|
Core Tip (1162)
|
Full Article (HTML) (6734)
|
Tables (1-2) (328)
|
Full Article (PDF)-872K (645)
|
Peer-Review Report-82K (305)
|
Answering Reviewers-100K (261)
|
Received: 05/16/2014
|
Revised: 07/04/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (15238)
|
Similar Articles (29)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Therapeutics Advances
World J Pharmacol
3(4):193-198.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.193
Abstract (1315)
|
Core Tip (1070)
|
Full Article (HTML) (2473)
|
Figures (1-2) (270)
|
Tables (1-1) (281)
|
Full Article (PDF)-1053K (358)
|
Peer-Review Report-98K (318)
|
Answering Reviewers-31K (179)
|
Received: 06/24/2014
|
Revised: 09/22/2014
|
Accepted: 10/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (11919)
|
Similar Articles (748)
|
Timeline of Article Publication (2)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Evidence-Based Medicine
World J Pharmacol
3(4):199-208.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.199
Abstract (1498)
|
Core Tip (1344)
|
Full Article (HTML) (6825)
|
Tables (1-4) (418)
|
Full Article (PDF)-1067K (587)
|
Peer-Review Report-118K (293)
|
Answering Reviewers-113K (313)
|
Received: 07/28/2014
|
Revised: 09/08/2014
|
Accepted: 10/16/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (14894)
|
Similar Articles (75)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Systematic Reviews
Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?

World J Pharmacol
3(4):209-216.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.209
Abstract (1548)
|
Core Tip (1242)
|
Full Article (HTML) (8937)
|
Figures (1-1) (307)
|
Tables (1-2) (491)
|
Full Article (PDF)-1014K (462)
|
Peer-Review Report-80K (284)
|
Answering Reviewers-67K (222)
|
Received: 05/21/2014
|
Revised: 07/14/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (17270)
|
Similar Articles (222)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open